High glucose increases B1-kinin receptor expression and signaling in endothelial cells

被引:19
作者
Rodriguez, Andres I. [1 ]
Pereira-Flores, Karla [1 ]
Hernandez-Salinas, Romina [1 ]
Boric, Mauricio P. [1 ]
Velarde, Victoria [1 ]
机构
[1] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Santiago, Chile
基金
美国国家卫生研究院;
关键词
signaling; kinins; B1; receptor; diabetes; endothelial dysfunction; iNOS;
D O I
10.1016/j.bbrc.2006.04.127
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The loss of endothelial function is the initiating factor in the development of diabetic vascular disease. Kinins control endothelial function by the activation of two receptors: the B2 which is constitutively expressed, and the B1 which is highly induced in pathological conditions. In the present study, we observed that the levels of B1-receptor mRNA and protein are induced in endothelial cells incubated in high glucose. An increase in B1-receptor was also observed in the endothelial layer of aortas, from 4-week diabetic rats. When cells were grown in high glucose, the B1 agonist des-Arg(9)-BK increased nitrite levels, whereas in normal glucose nitrite levels were unchanged. Nitrite increase was blocked by L-NAME and 1400W indicating the participation of the inducible Nitric Oxide Synthase (iNOS). iNOS protein levels were also increased in high glucose. These results demonstrate the participation of the B1 receptor in the signaling pathways mediated by kinins in high glucose. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:652 / 659
页数:8
相关论文
共 45 条
[1]   Early upregulation of kinin B1 receptors in retinal microvessels of the streptozotocin-diabetic rat [J].
Abdouh, M ;
Khanjari, A ;
Abdelazziz, N ;
Ongali, B ;
Couture, R ;
Hasséssian, HM .
BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140 (01) :33-40
[2]   Bradykinin B1 receptor mediates inhibition of neointima formation in rat artery after balloon angioplasty [J].
Agata, J ;
Miao, RQ ;
Yayama, K ;
Chao, L ;
Chao, J .
HYPERTENSION, 2000, 36 (03) :364-370
[3]   Nitric oxide synthases: structure, function and inhibition [J].
Alderton, WK ;
Cooper, CE ;
Knowles, RG .
BIOCHEMICAL JOURNAL, 2001, 357 (03) :593-615
[4]  
Bardell AL, 2001, J PHARMACOL EXP THER, V296, P252
[5]  
BHOOLA KD, 1992, PHARMACOL REV, V44, P1
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]   Molecular and pharmacological evidence for modulation of kinin B1 receptor expression by endogenous glucocorticoids hormones in rats [J].
Cabrini, DA ;
Campos, MM ;
Tratsk, KS ;
Merino, VF ;
Silva, JA ;
Souza, GEP ;
Avellar, MCW ;
Pesquero, JB ;
Calixto, JB .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 132 (02) :567-577
[8]   MEKK3 directly regulates MEK5 activity as part of the big mitogen-activated protein kinase 1 (BMK1) signaling pathway [J].
Chao, TH ;
Hayashi, M ;
Tapping, RI ;
Kato, Y ;
Lee, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (51) :36035-36038
[9]   Diabetes modulates the expression of glomerular kinin receptors [J].
Christopher, J ;
Jaffa, AA .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2002, 2 (13-14) :1771-1779
[10]   Induction of B1-kinin receptors in vascular smooth muscle cells:: Cellular mechanisms of MAP kinase activation [J].
Christopher, J ;
Velarde, V ;
Jaffa, AA .
HYPERTENSION, 2001, 38 (03) :602-605